GI Innovation, Inc.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS5
PHASE 3 / 2-30
RECRUITING5
READOUTS ≤12 MONTHS1
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| GI-102 subcutaneous (SC) NCT05824975 |
P1/2 | Recruiting | Advanced Solid Tumor; Metastatic Solid Tumor | 358 | 2025-11-12 |
| GIANTS-1 NCT07363057 |
P2 | Recruiting | Cancer Survivors; Healthy Participant | 15 | 2026-05 |
| GI-108 NCT07172802 |
P1/2 | Recruiting | Advanced Solid Tumor; Metastatic Solid Tumor | 102 | 2027-02 |
| GI-101 NCT04977453 |
P1/2 | Recruiting | Advanced Solid Tumor; Metastatic Solid Tumor | 317 | 2028-06-30 (+34 mo) |
| GI-102 NCT07871435 |
P1/2 | Recruiting | Metastatic Castration-resistant Prostate Cancer (mCRPC) | 107 | 2029-03-31 |